The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

Elevated Glasgow Prognostic Score (GPS) has been related to poor prognosis in patients with hepatocellular carcinoma (HCC) undergoing surgical resection or receiving sorafenib. The aim of this study was to investigate the prognostic value of GPS in patients with various stages of the disease and wit...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 13; no. 1; p. 52
Main Authors Kinoshita, Akiyoshi, Onoda, Hiroshi, Imai, Nami, Iwaku, Akira, Oishi, Mutumi, Tanaka, Ken, Fushiya, Nao, Koike, Kazuhiko, Nishino, Hirokazu, Matsushima, Masato, Saeki, Chisato, Tajiri, Hisao
Format Journal Article
LanguageEnglish
Published England BioMed Central 02.02.2013
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Elevated Glasgow Prognostic Score (GPS) has been related to poor prognosis in patients with hepatocellular carcinoma (HCC) undergoing surgical resection or receiving sorafenib. The aim of this study was to investigate the prognostic value of GPS in patients with various stages of the disease and with different liver functional status. One hundred and fifty patients with newly diagnosed HCC were prospectively evaluated. Patients were divided according to their GPS scores. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with overall survival; the identified variables were then compared with those of other validated staging systems. Elevated GPS were associated with increased asparate aminotransferase (P<0.0001), total bilirubin (P<0.0001), decreased albumin (P<0.0001), α-fetoprotein (P=0.008), larger tumor diameter (P=0.003), tumor number (P=0.041), vascular invasion (P=0.0002), extra hepatic metastasis (P=0.02), higher Child-Pugh scores (P<0.0001), and higher Cancer Liver Italian Program scores (P<0.0001). On multivariate analysis, the elevated GPS was independently associated with worse overall survival. Our results demonstrate that the GPS can serve as an independent marker of poor prognosis in patients with HCC in various stages of disease and different liver functional status.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:1471-2407
1471-2407
DOI:10.1186/1471-2407-13-52